Paloma Partners’s Asensus Surgical, Inc. ASXC Stock Holding History

Paloma Partners’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-132,227	Closed	-$419K	–	2029
2021 Q2	$419K	Buy	+132,227	New	+$330K	0.01%	1121
2020 Q3	–	Sell	-141,257	Closed	-$76K	–	2554
2020 Q2	$76K	Buy	+141,257	New	+$68.2K	﹤0.01%	1947
2019 Q4	–	Sell	-3,323	Closed	-$27K	–	2587
2019 Q3	$27K	Buy	3,323 +1,812	+120%	+$24.6K	﹤0.01%	1890
2019 Q2	$27K	Buy	+1,511	New	+$33.1K	﹤0.01%	1669
2017 Q3	–	Sell	-19,831	Closed	-$183K	–	2517
2017 Q2	$183K	Buy	+19,831	New	+$189K	﹤0.01%	2018

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Paloma Partners's ASXC Position: Q3 2021 in Review

Paloma Partners sold out of Asensus Surgical, Inc. (ASXC) in Q3 2021, closing a stake of 132,227 shares — an estimated $419K sold.

Paloma Partners first reported a position in ASXC in Q2 2017 and held it in 5 quarters. The position peaked at $419K in Q2 2021. 111 funds tracked by Wall St. Rank hold ASXC as of Q3 2021.

Paloma Partners reported no remaining Asensus Surgical, Inc. position as of Q3 2021 after selling out during the quarter.
Paloma Partners sold 132,227 Asensus Surgical, Inc. shares in Q3 2021, an estimated $419K.
Paloma Partners first reported a position in Asensus Surgical, Inc. in Q2 2017 and held it in 5 quarters.
Paloma Partners's Asensus Surgical, Inc. position peaked at $419K in Q2 2021.
111 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2021.

Based on Paloma Partners's 13F filing for Q3 2021, filed 15 Nov 2021.